SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-030356
Filing Date
2023-03-09
Accepted
2023-03-09 08:46:47
Documents
20
Period of Report
2023-03-09
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm238149d1_8k.htm   iXBRL 8-K 35361
2 EXHIBIT 4.1 tm238149d1_ex4-1.htm EX-4.1 91184
3 EXHIBIT 5.1 tm238149d1_ex5-1.htm EX-5.1 18898
4 EXHIBIT 10.1 tm238149d1_ex10-1.htm EX-10.1 199637
5 EXHIBIT 99.1 tm238149d1_ex99-1.htm EX-99.1 13344
10 GRAPHIC tm238149d1_ex5-1img02.jpg GRAPHIC 10360
11 GRAPHIC tm238149d1_ex5-1img01.jpg GRAPHIC 11176
12 GRAPHIC tm238149d1_ex99-1img004.jpg GRAPHIC 2072
  Complete submission text file 0001104659-23-030356.txt   679828

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA nrxp-20230309.xsd EX-101.SCH 3508
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nrxp-20230309_def.xml EX-101.DEF 26545
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE nrxp-20230309_lab.xml EX-101.LAB 36481
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nrxp-20230309_pre.xml EX-101.PRE 25169
14 EXTRACTED XBRL INSTANCE DOCUMENT tm238149d1_8k_htm.xml XML 5158
Mailing Address 1201 ORANGE STREET SUITE 600 WILMINGTON DE 19801
Business Address 1201 ORANGE STREET SUITE 600 WILMINGTON DE 19801 484-254-6134
NRX Pharmaceuticals, Inc. (Filer) CIK: 0001719406 (see all company filings)

IRS No.: 822844431 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38302 | Film No.: 23718328
SIC: 2834 Pharmaceutical Preparations